Morgan Stanley analyst Michael Ulz downgraded AlloVir to Underweight from Equal Weight with a 50c price target.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALVR:
- Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
- AlloVir downgraded to Underperform from Buy at BofA
- AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
- AlloVir downgraded to Market Perform from Outperform at Leerink
- Nike downgraded, Waste Management upgraded: Wall Street’s top analyst calls
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue